lncRNA HCG22 regulated cell growth and metastasis of papillary thyroid cancer via negatively modulating miR-425-5p
Endokrynologia Polska · 2024
DOI: 10.5603/ep.97425 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endokrynologia Polska, 2024. Verfasst von Xuepeng Cao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical School, Hexi University, Zhangye, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Thyroid Neoplasms, MicroRNAs. Die Arbeit wurde bisher 7-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical School, Hexi University, Zhangye, China.
- Surgery Wound Department, Beijing Haidian Hospital, Beijing, China.
- Department of General Surgery (Thyroid Gland/Blood Vessel), The First People' Hospital o Neijiang, Neijiang, China.
- Department of General Surgery (Thyroid Gland/Blood Vessel), The First People' Hospital o Neijiang, Neijiang, China. huangjianyuan7388@163.com.
Zitieren
APA
Cao, X., Ma, C., Wu, Y., & Huang, J. (2024). lncRNA HCG22 regulated cell growth and metastasis of papillary thyroid cancer via negatively modulating miR-425-5p. Endokrynologia Polska. https://doi.org/10.5603/ep.97425
Vancouver
Cao X, Ma C, Wu Y, Huang J. lncRNA HCG22 regulated cell growth and metastasis of papillary thyroid cancer via negatively modulating miR-425-5p. Endokrynologia Polska. 2024. doi:10.5603/ep.97425
BibTeX
@article{Cao2024,
author = {Cao, Xuepeng and Ma, Chuang and Wu, Yang and Huang, Jianyuan},
title = {lncRNA HCG22 regulated cell growth and metastasis of papillary thyroid cancer via negatively modulating miR-425-5p},
journal = {Endokrynologia Polska},
year = {2024},
doi = {10.5603/ep.97425}
}
EUVIMED